Semaglutide medications Marketed for Type 2 Diabetes or Weight Loss - Warning and risks, USA
4 months ago •source fda.gov • details
Outbreak
On December 21, 2023, the FDA published a warning to consumers, healthcare providers, and pharmacists to not use counterfeit Ozempic (semaglutide) injection 1 milligram, which has entered the U.S. drug supply chain. This counterfeit product is labeled with lot number NAR0074 and serial number 430834149057. FDA…